Focus

Pharma Investors: Angels and VC Firms

The RaiseHunt database lists 3,592 Pharma investors: 100 angel investors and 3,492 people at 1,040 firms. Most list Seed and Series A among their stages; the largest hubs are New York, London and Paris.

Strongest in New York, London and Paris

Common stages: Seed and Series A

3,592: Pharma investors
100: Angel investors
3,492: People at VC/PE firms
1,040: Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

3,592 Pharma investors

Showing 461-480

Filters

Viewing

Pharma3,592

Investor Type

Choosing one replaces Pharma.

See all 13→

Investment Stage

Choosing one replaces Pharma.

Seed84,741
Series A53,994
Late-Stage37,936
Series B35,863
Growth34,734
Pre-Seed32,476

See all 6→

Investment Profile

Choosing one replaces Pharma.

SaaS63,482
FinTech54,181
Healthcare53,462
Consumer46,733
AI46,186
Hardware36,505
Commerce32,771
Climate23,313
Real Estate17,905
Education13,608
Food10,848
Travel7,449
Energy946
Agriculture555

See all 14→

Country

Choosing one replaces Pharma.

See all 186→

City

Choosing one replaces Pharma.

See all 694→

Focus1

See all 802→

Investor	Location	Type	Markets	Actions
David G. Cheng General Partner at Costanoa Ventures	San Francisco, United States	Venture capital	AICommerce	View profile
Tunde Akinniranye Digital Health Unit at Nestlé Health Science	Chicago, United States	Corporate VC	FoodHealthcare	View profile
Jeff Terrell Partner at Arboretum Ventures	Durham, United States	Venture capital	HardwareHealthcare	View profile
Craig H. Boyce Managing Partner at ALS Investment Fund	Boston, United States	Venture capital	Healthcare	View profile
Delphine Dinard Executive Director at Tikehau Capital	Paris, France	Private equityVenture debt	ClimateConsumer	View profile
Francis X. Suarez President at Alpha Wave Global	United States	Private equityVenture debt	AICommerce	View profile
Glenn Rockman Founder and Managing Partner at Adjuvant Capital	New York, United States	Private equityVenture capital	ClimateFinTech	View profile
Joseph Chittenden-Veal Investor at Visionary Venture Fund	New York, United States	Venture capital	Healthcare	View profile
Diya Malhotra Principal at Abingworth	London, United Kingdom	Venture capital	Healthcare	View profile
Kurt von Emster Managing Partner at Abingworth	Menlo Park, United States	Operator-ledVenture capital	Healthcare	View profile
Christine Borowski Principal at Access Industries	New York City, United States	Private equityVenture capital	ConsumerHealthcare	View profile
Hayal Koc Investor & LP at Emmeline Ventures	London, United Kingdom	AcceleratorVenture capital	AIClimate	View profile
Jim Momtazee Managing Partner at Patient Square Capital	Menlo Park, United States	Private equityVenture capital	FinTechHardware	View profile
Richard Svinkin AI Product Mgt., Angel Investor at Astellas Pharma	New York, United States	Corporate VCVenture capital	AICommerce	View profile
Benjamin Lund Partner at Soleus Capital Management	New York, United States	Private equityVenture debt	Healthcare	View profile
Andrew Kaplan Board Observer at Tanabe Pharma America	Boston, United States	Corporate VCPrivate equity	AICommerce	View profile
Gilles Daguet Managing Director at Tikehau Capital	Paris, France	Private equityVenture debt	ClimateConsumer	View profile
Ian Howes CFO and Managing Director at Accelerator Life Science Partners	Chapel Hill, United States	Accelerator	Healthcare	View profile
Paul McCreadie Managing Partner & COO at Arboretum Ventures	Ann Arbor, United States	Venture capital	HardwareHealthcare	View profile
Tom Harbin Investor at Source Capital	Atlanta, United States	Private equityVenture debt	CommerceConsumer	View profile

Data: RaiseHunt investor dataset · Snapshot 16 October 2026 · How this data is built · Report a correction or request removal